NO20083269L - Prosess for a anvende krystallinsk orlistatmetoder - Google Patents

Prosess for a anvende krystallinsk orlistatmetoder

Info

Publication number
NO20083269L
NO20083269L NO20083269A NO20083269A NO20083269L NO 20083269 L NO20083269 L NO 20083269L NO 20083269 A NO20083269 A NO 20083269A NO 20083269 A NO20083269 A NO 20083269A NO 20083269 L NO20083269 L NO 20083269L
Authority
NO
Norway
Prior art keywords
methods
orlistat
crystalline
crystalline orlistat
crystalline form
Prior art date
Application number
NO20083269A
Other languages
English (en)
Inventor
Andrejka Kramar
Igor Simonic
Primoz Benkic
Anton Stimac
Anamarija Vajs
Original Assignee
Krka Tovarna Zdravil Dd Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36354129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083269(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka Tovarna Zdravil Dd Novo Mesto filed Critical Krka Tovarna Zdravil Dd Novo Mesto
Publication of NO20083269L publication Critical patent/NO20083269L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Det er beskrevet en fremgangsmåte for fremstilling av krystallinske former av orlistat, spesielt orlistat krystallinsk Form I og orlistat krystallinsk Form II.
NO20083269A 2005-12-27 2008-07-23 Prosess for a anvende krystallinsk orlistatmetoder NO20083269L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05028489A EP1803714A1 (en) 2005-12-27 2005-12-27 Process for preparing crystalline forms of orlistat
PCT/EP2006/012544 WO2007073937A2 (en) 2005-12-27 2006-12-27 Process for preparing crystalline forms of orlistat

Publications (1)

Publication Number Publication Date
NO20083269L true NO20083269L (no) 2008-09-19

Family

ID=36354129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083269A NO20083269L (no) 2005-12-27 2008-07-23 Prosess for a anvende krystallinsk orlistatmetoder

Country Status (5)

Country Link
EP (2) EP1803714A1 (no)
EA (1) EA015940B1 (no)
NO (1) NO20083269L (no)
UA (1) UA91733C2 (no)
WO (1) WO2007073937A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803714A1 (en) 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat
SI2002825T1 (sl) * 2007-06-14 2013-10-30 Krka Farmacevtski sestavki, ki obsegajo orlistat
WO2009040827A1 (en) * 2007-09-24 2009-04-02 Biocon Limited A process for obtaining tetrahydrolipstatin
EP2141236A1 (en) 2008-07-03 2010-01-06 KRKA, D.D., Novo Mesto Process for production of lipstatin and microorganisms therefore
EP2389370A4 (en) * 2009-01-22 2012-09-05 Biocon Ltd CRYSTALLINE FORM OF ORLISTAT AND METHOD THEREFOR
CN111343999B (zh) 2017-07-12 2022-03-01 梅约医学教育与研究基金会 减少脂毒性损伤的化合物
CN114555061B (zh) * 2019-10-18 2023-08-15 山东新时代药业有限公司 一种奥利司他胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
DK1028115T3 (da) * 1999-01-29 2003-03-17 Hoffmann La Roche Oprensning af lipstatin
RU2241462C2 (ru) * 2000-07-28 2004-12-10 Ф. Хоффманн-Ля Рош Аг Новая фармацевтическая композиция
EP1311260B1 (en) * 2000-08-09 2008-04-02 F. Hoffmann-La Roche Ag Lipase inhibitors to treat dyspepsia
US6734314B2 (en) * 2001-12-04 2004-05-11 Biogal Gyogyszergyar Rt. Preparation of orlistat and orlistat crystalline forms
PT1673359E (pt) * 2003-09-12 2009-10-06 Ranbaxy Lab Ltd Processo para a preparação de formas cristalinas de orlistat
EP1803714A1 (en) 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat

Also Published As

Publication number Publication date
EP1973893A2 (en) 2008-10-01
WO2007073937A2 (en) 2007-07-05
UA91733C2 (ru) 2010-08-25
EP1973893B1 (en) 2015-04-29
WO2007073937A3 (en) 2007-08-23
EA200801573A1 (ru) 2008-10-30
EP1803714A1 (en) 2007-07-04
EA015940B1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
NO20083269L (no) Prosess for a anvende krystallinsk orlistatmetoder
NO20082305L (no) Mikrobiologisk stabilisert ol
DE602004013405D1 (de) Polymorphe formen von valsartan
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
DK1654438T3 (da) Fremgangsmåde til naturgasproduktion
NZ592897A (en) Crystals of laquinimod sodium, and process for the manufacture thereof
WO2008066558A3 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
UA89390C2 (ru) Способ получения аннелированных производных пиперазин-2-она та соответствующие промежуточные продукты
CY1112583T1 (el) Μεθοδος για την παραγωγη ασβεστουχου ατορβαστατινης σε αμορφη μορφη
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
NO20071309L (no) Fremgangsmate for ekspansjon
GEP20094785B (en) Pyrrolopyrazoles, potent kinase inhibitors
TW200720232A (en) Crystalline solid forms of tigecycline and methods of preparing same
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
EP1916241A4 (en) CRYSTAL OF A PHENYLALANINE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
NO20075557L (no) Krystaller av morfinanderivat og fremgangsmate for fremstilling derav
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
NO20051393L (no) Prosess og intermediater for fremstilling av tienopyrrol-derivater
EP1702508A4 (en) METHOD FOR PRODUCING A STERILE PLANT, PLANT OBTAINED BY THE METHOD, AND USE THEREOF
DK1968592T3 (da) Formuleringer omfattende jorumycin-, renieramycin-, safracin- eller saframycin-relaterede forbindelser og et disaccharid til behandling af proliferative sygdomme
NO20092690L (no) Aminderivater og deres anvendelse i beta-2-adrenoreseptormedierte sykdommer
MX2010003333A (es) Sal de amina organica de 6-fluoro-3-hidroxi-2-pirazincarbonitrilo y metodo para su produccion.
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application